LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 892

Search options

  1. Article ; Online: Clinical Characteristics of Covid-19 in China.

    Chen, Andre T C / Coura-Filho, George B / Rehder, Marília H H

    The New England journal of medicine

    2020  Volume 382, Issue 19, Page(s) 1860

    MeSH term(s) Betacoronavirus ; COVID-19 ; China ; Coronavirus ; Coronavirus Infections ; Humans ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-03-27
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMc2005203
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53α.

    Roselle, Christopher / Horikawa, Izumi / Chen, Linhui / Kelly, Andre R / Gonzales, Donna / Da, Tong / Wellhausen, Nils / Rommel, Philipp C / Baker, Daniel / Suhoski, Megan / Scholler, John / O'Connor, Roddy S / Young, Regina M / Harris, Curtis C / June, Carl H

    Proceedings of the National Academy of Sciences of the United States of America

    2024  Volume 121, Issue 10, Page(s) e2317735121

    Abstract: Chimeric antigen receptor (CAR) T cell dysfunction is a major barrier to achieving lasting ... that Δ133p53α, an endogenous isoform of the human TP53 gene, decreases in expression with age in human T ... cells, and that reconstitution of Δ133p53α in poorly functional T cells can rescue proliferation [A. M ...

    Abstract Chimeric antigen receptor (CAR) T cell dysfunction is a major barrier to achieving lasting remission in hematologic cancers, especially in chronic lymphocytic leukemia (CLL). We have shown previously that Δ133p53α, an endogenous isoform of the human TP53 gene, decreases in expression with age in human T cells, and that reconstitution of Δ133p53α in poorly functional T cells can rescue proliferation [A. M. Mondal
    MeSH term(s) Humans ; Immunotherapy, Adoptive/methods ; Leukemia, Lymphocytic, Chronic, B-Cell/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell/therapy ; Receptors, Chimeric Antigen/genetics ; Receptors, Chimeric Antigen/metabolism ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism ; Antigens, CD19 ; Cell- and Tissue-Based Therapy ; Receptors, Antigen, T-Cell/genetics ; Receptors, Antigen, T-Cell/metabolism
    Chemical Substances Receptors, Chimeric Antigen ; Tumor Suppressor Protein p53 ; Antigens, CD19 ; Receptors, Antigen, T-Cell
    Language English
    Publishing date 2024-02-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.2317735121
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Brazilian Landscape of Hepatocellular Carcinoma.

    Fonseca, Leonardo G / Chen, Andre T C / de Oliveira, Irai S / Chagas, Aline L / Kruger, Jaime A P / Carrilho, Flair J

    JCO global oncology

    2023  Volume 9, Page(s) e2200416

    Abstract: The incidence of hepatocellular carcinoma (HCC) is expected to increase in the coming years, and strategies to mitigate the burden of this disease are needed in different regions. Geographic variations in epidemiology and risk factors, such as viral ... ...

    Abstract The incidence of hepatocellular carcinoma (HCC) is expected to increase in the coming years, and strategies to mitigate the burden of this disease are needed in different regions. Geographic variations in epidemiology and risk factors, such as viral hepatitis and metabolic disease, pose challenges in adopting programs for early detection programs and management of patients with HCC. Brazil, like other countries, has high economic and social inequality, with heterogeneous access to health care. Viral hepatitis is the main risk factor but there is growing awareness of fatty liver disease. Risk factor monitoring and screening programs are unmet priorities because patients are often diagnosed at later stages. Advances in the management of patients with HCC have been made in recent years, including new tools for selecting patients for liver transplantation, sophisticated surgical techniques, and new systemic agents. High-volume academic centers often achieve favorable results through the adoption and application of established treatments, but this is not a reality in most regions of Brazil, because of disparities in wealth and resources. As HCC management requires a coordinated and multidisciplinary team, the role of local referral centers in decentralizing access to treatments and promoting health education in different regions should be encouraged and supported.
    MeSH term(s) Humans ; Carcinoma, Hepatocellular/diagnosis ; Carcinoma, Hepatocellular/epidemiology ; Carcinoma, Hepatocellular/therapy ; Liver Neoplasms/diagnosis ; Liver Neoplasms/epidemiology ; Liver Neoplasms/therapy ; Brazil/epidemiology ; Risk Factors ; Incidence
    Language English
    Publishing date 2023-06-20
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2687-8941
    ISSN (online) 2687-8941
    DOI 10.1200/GO.22.00416
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Trends in Outcomes of Heart Transplants Using Extended Criteria Donors: A United Network for Organ Sharing Database Analysis.

    Critsinelis, Andre C / Patel, Sagar / Nordan, Taylor / Chen, Frederick Y / Couper, Gregory S / Kawabori, Masashi

    The Annals of thoracic surgery

    2022  Volume 115, Issue 6, Page(s) 1503–1509

    Abstract: ... to 2014, and (4) 2014 to 2018. The 2-sample t test, Kaplan-Meier survival analysis, log-rank test ...

    Abstract Background: Although the use of extended criteria donors (ECDs) is traditionally avoided because of poorer outcomes, management of heart transplant (HTx) recipients has evolved over the past decades. We sought to examine the temporal trends in outcomes of ECDs in HTx.
    Methods: We queried the United Network for Organ Sharing database for adult HTx recipients who fit the EXPAND Trial criteria for ECDs: ischemic time ≥ 4 hours, ejection fraction < 50%, age > 55 years, and history of coronary artery disease. Transplant years were stratified into the following 4 periods: (1) 2000 to 2004, (2) 2005 to 2009, (3) 2010 to 2014, and (4) 2014 to 2018. The 2-sample t test, Kaplan-Meier survival analysis, log-rank test, analysis of variance, multivariable Cox proportional hazards, and multinomial logistic regression were used to compare data between periods.
    Results: Through periods 1 to 4, 39,028 patients were stratified as follows: 9217 (2942 ECDs, 31.9%), 9224 (2730 ECDs, 29.6%), 10,309 (2762 ECDs, 26.8%), and 10,278 (2190 ECDs, 21.3%). Transplants using ECDs in periods 1 and 2 had increased 1-year mortality compared with periods 3 and 4 (16.9% and 15.6% vs 11.9% and 10.9% respectively, P < .001). Later periods also demonstrated improved Karnofsky scores (P < .001).
    Conclusions: Although use of ECDs decreased across the periods, we noted significant improvement in 1-year survival rates and postoperative functional status.
    MeSH term(s) Adult ; Humans ; Middle Aged ; Kidney Transplantation ; Retrospective Studies ; Tissue Donors ; Heart Transplantation ; Kaplan-Meier Estimate ; Treatment Outcome ; Graft Survival
    Language English
    Publishing date 2022-09-28
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 211007-6
    ISSN 1552-6259 ; 0003-4975
    ISSN (online) 1552-6259
    ISSN 0003-4975
    DOI 10.1016/j.athoracsur.2022.09.027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Dietary advanced glycation end-products (dAGEs) intake and its relation to sarcopenia and frailty - The Rotterdam Study.

    Waqas, Komal / Chen, Jinluan / Lu, T / van der Eerden, B C J / Rivadeneira, Fernando / Uitterlinden, André G / Voortman, Trudy / Zillikens, M Carola

    Bone

    2022  Volume 165, Page(s) 116564

    Abstract: Studies on mice have shown a relationship between dietary intake of advanced glycation end-products (dAGEs) and deterioration of musculoskeletal health, but human studies are absent. We investigated the relationship between dietary intake of ... ...

    Abstract Studies on mice have shown a relationship between dietary intake of advanced glycation end-products (dAGEs) and deterioration of musculoskeletal health, but human studies are absent. We investigated the relationship between dietary intake of carboxymethyllysine (dCML) - an AGE prototype - and risk of sarcopenia at baseline and after 5 years of follow-up and a single evaluation of physical frailty in participants from the population-based Rotterdam Study. Appendicular lean mass (ALM) was obtained using insight dual-energy X-ray absorptiometry and hand grip strength (HGS) using a hydraulic hand dynamometer. Subjects with both low ALM and weak HGS were classified as having sarcopenia. Frailty (yes/no) was defined by presence of ≥3 and pre-frailty by presence of 1 or 2 components namely, exhaustion, weakness, slowness, weight loss or low physical activity. dCML was calculated using a food frequency questionnaire and dAGE databases. Logistic regression analysis was used to evaluate the odds of physical frailty and prevalent sarcopenia at baseline and follow-up and incident sarcopenia. 2782 participants with an age 66.4 ± 9.9 years and dCML intake 3.3 ± 1.3 mg/day, had data on sarcopenia at both time points. Of whom 84 had sarcopenia at baseline and 73 developed sarcopenia at follow-up. We observed an association of one SD increase in dCML intake with prevalent sarcopenia at baseline [odds ratio, OR = 1.27 (1.01-1.59)] and no association of dCML with incident sarcopenia at 5-year follow-up [OR = 1.12 (0.86-1.44)]. For frailty we analyzed 3577 participants, of whom 1972 were pre-frail and 158 were frail. We observed no association of dCML with either pre-frailty [OR = 0.99 (0.91-1.07)] or frailty [OR = 1.01 (0.83-1.22)] when non-frail subjects were used as reference. Our results show an association of dAGEs with sarcopenia cross-sectionally but not longitudinally where inconclusive findings are observed possibly due to a very low incidence of sarcopenia. There was no association with frailty cross-sectionally.
    MeSH term(s) Humans ; Mice ; Animals ; Child, Preschool ; Middle Aged ; Aged ; Frailty/epidemiology ; Sarcopenia/epidemiology ; Hand Strength ; Glycation End Products, Advanced ; Eating
    Chemical Substances Glycation End Products, Advanced
    Language English
    Publishing date 2022-09-21
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 632515-4
    ISSN 1873-2763 ; 8756-3282
    ISSN (online) 1873-2763
    ISSN 8756-3282
    DOI 10.1016/j.bone.2022.116564
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Cyclophilin A supports translation of intrinsically disordered proteins and affects haematopoietic stem cell ageing.

    Maneix, Laure / Iakova, Polina / Lee, Charles G / Moree, Shannon E / Lu, Xuan / Datar, Gandhar K / Hill, Cedric T / Spooner, Eric / King, Jordon C K / Sykes, David B / Saez, Borja / Di Stefano, Bruno / Chen, Xi / Krause, Daniela S / Sahin, Ergun / Tsai, Francis T F / Goodell, Margaret A / Berk, Bradford C / Scadden, David T /
    Catic, André

    Nature cell biology

    2024  Volume 26, Issue 4, Page(s) 593–603

    Abstract: Loss of protein function is a driving force of ageing. We have identified peptidyl-prolyl isomerase A (PPIA or cyclophilin A) as a dominant chaperone in haematopoietic stem and progenitor cells. Depletion of PPIA accelerates stem cell ageing. We found ... ...

    Abstract Loss of protein function is a driving force of ageing. We have identified peptidyl-prolyl isomerase A (PPIA or cyclophilin A) as a dominant chaperone in haematopoietic stem and progenitor cells. Depletion of PPIA accelerates stem cell ageing. We found that proteins with intrinsically disordered regions (IDRs) are frequent PPIA substrates. IDRs facilitate interactions with other proteins or nucleic acids and can trigger liquid-liquid phase separation. Over 20% of PPIA substrates are involved in the formation of supramolecular membrane-less organelles. PPIA affects regulators of stress granules (PABPC1), P-bodies (DDX6) and nucleoli (NPM1) to promote phase separation and increase cellular stress resistance. Haematopoietic stem cell ageing is associated with a post-transcriptional decrease in PPIA expression and reduced translation of IDR-rich proteins. Here we link the chaperone PPIA to the synthesis of intrinsically disordered proteins, which indicates that impaired protein interaction networks and macromolecular condensation may be potential determinants of haematopoietic stem cell ageing.
    MeSH term(s) Intrinsically Disordered Proteins/chemistry ; Cyclophilin A/genetics ; Cyclophilin A/metabolism ; RNA-Binding Proteins ; Hematopoietic Stem Cells/metabolism
    Chemical Substances Intrinsically Disordered Proteins ; Cyclophilin A (EC 5.2.1.-) ; RNA-Binding Proteins
    Language English
    Publishing date 2024-03-29
    Publishing country England
    Document type Journal Article
    ZDB-ID 1474722-4
    ISSN 1476-4679 ; 1465-7392
    ISSN (online) 1476-4679
    ISSN 1465-7392
    DOI 10.1038/s41556-024-01387-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Engineering self-propelled tumor-infiltrating CAR T cells using synthetic velocity receptors.

    Johnston, Adrian C / Alicea, Gretchen M / Lee, Cameron C / Patel, Payal V / Hanna, Eban A / Vaz, Eduarda / Forjaz, André / Wan, Zeqi / Nair, Praful R / Lim, Yeongseo / Chen, Tina / Du, Wenxuan / Kim, Dongjoo / Nichakawade, Tushar D / Rebecca, Vito W / Bonifant, Challice L / Fan, Rong / Kiemen, Ashley L / Wu, Pei-Hsun /
    Wirtz, Denis

    bioRxiv : the preprint server for biology

    2024  

    Abstract: Chimeric antigen receptor (CAR) T cells express antigen-specific synthetic receptors ... which upon binding to cancer cells, elicit T cell anti-tumor responses. CAR T cell therapy has enjoyed success ... However, CAR T therapy for patients with solid tumors has not seen similar success. Solid tumors constitute 90 ...

    Abstract Chimeric antigen receptor (CAR) T cells express antigen-specific synthetic receptors, which upon binding to cancer cells, elicit T cell anti-tumor responses. CAR T cell therapy has enjoyed success in the clinic for hematological cancer indications, giving rise to decade-long remissions in some cases. However, CAR T therapy for patients with solid tumors has not seen similar success. Solid tumors constitute 90% of adult human cancers, representing an enormous unmet clinical need. Current approaches do not solve the central problem of limited ability of therapeutic cells to migrate through the stromal matrix. We discover that T cells at low and high density display low- and high-migration phenotypes, respectively. The highly migratory phenotype is mediated by a paracrine pathway from a group of self-produced cytokines that include IL5, TNFα, IFNγ, and IL8. We exploit this finding to "lock-in" a highly migratory phenotype by developing and expressing receptors, which we call velocity receptors (VRs). VRs target these cytokines and signal through these cytokines' cognate receptors to increase T cell motility and infiltrate lung, ovarian, and pancreatic tumors in large numbers and at doses for which control CAR T cells remain confined to the tumor periphery. In contrast to CAR therapy alone, VR-CAR T cells significantly attenuate tumor growth and extend overall survival. This work suggests that approaches to the design of immune cell receptors that focus on migration signaling will help current and future CAR cellular therapies to infiltrate deep into solid tumors.
    Language English
    Publishing date 2024-03-26
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.12.13.571595
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Azepine-Indole Alkaloids From

    Kirchweger, Benjamin / Klein-Junior, Luiz C / Pretsch, Dagmar / Chen, Ya / Cretton, Sylvian / Gasper, André L / Heyden, Yvan Vander / Christen, Philippe / Kirchmair, Johannes / Henriques, Amélia T / Rollinger, Judith M

    Frontiers in neuroscience

    2022  Volume 16, Page(s) 826289

    Abstract: Nemorosine A ( ...

    Abstract Nemorosine A (
    Language English
    Publishing date 2022-03-14
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2411902-7
    ISSN 1662-453X ; 1662-4548
    ISSN (online) 1662-453X
    ISSN 1662-4548
    DOI 10.3389/fnins.2022.826289
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Photocleavable Polymer Cubosomes: Synthesis, Self-Assembly, and Photorelease.

    Chen, Hui / Schumacher, Marcel / Ianiro, Alessandro / Stank, Tim Julian / Janoszka, Nicole / Chen, Chen / Azhdari, Suna / Hellweg, Thomas / Gröschel, André H

    Journal of the American Chemical Society

    2024  

    Abstract: Polymer cubosomes (PCs) are a recent class of self-assembled block copolymer (BCP) microparticles with an accessible periodic channel system. Most reported PCs consist of a polystyrene scaffold, which provides mechanical stability for templating but has ... ...

    Abstract Polymer cubosomes (PCs) are a recent class of self-assembled block copolymer (BCP) microparticles with an accessible periodic channel system. Most reported PCs consist of a polystyrene scaffold, which provides mechanical stability for templating but has a limited intrinsic functionality. Here, we report the synthesis of photocleavable BCPs with compositions suitable for PC formation. We analyze the self-assembly mechanism and study the model release of dyes during irradiation, where the transition of the BCPs from amphiphilic to bishydrophilic causes the rapid disassembly of the PCs. A combination of modeling and experiment shows that the evolution of PCs proceeds first
    Language English
    Publishing date 2024-04-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3155-0
    ISSN 1520-5126 ; 0002-7863
    ISSN (online) 1520-5126
    ISSN 0002-7863
    DOI 10.1021/jacs.4c02651
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Dietary advanced glycation end-products (dAGEs) intake and its relation to sarcopenia and frailty – The Rotterdam Study

    Waqas, Komal / Chen, Jinluan / Lu, T. / van der Eerden, B.C.J. / Rivadeneira, Fernando / Uitterlinden, André G. / Voortman, Trudy / Zillikens, Carola

    Bone

    2022  Volume 165

    Abstract: Studies on mice have shown a relationship between dietary intake of advanced glycation end-products (dAGEs) and deterioration of musculoskeletal health, but human studies are absent. We investigated the relationship between dietary intake of ... ...

    Abstract Studies on mice have shown a relationship between dietary intake of advanced glycation end-products (dAGEs) and deterioration of musculoskeletal health, but human studies are absent. We investigated the relationship between dietary intake of carboxymethyllysine (dCML) – an AGE prototype – and risk of sarcopenia at baseline and after 5 years of follow-up and a single evaluation of physical frailty in participants from the population-based Rotterdam Study. Appendicular lean mass (ALM) was obtained using insight dual-energy X-ray absorptiometry and hand grip strength (HGS) using a hydraulic hand dynamometer. Subjects with both low ALM and weak HGS were classified as having sarcopenia. Frailty (yes/no) was defined by presence of ≥3 and pre-frailty by presence of 1 or 2 components namely, exhaustion, weakness, slowness, weight loss or low physical activity. dCML was calculated using a food frequency questionnaire and dAGE databases. Logistic regression analysis was used to evaluate the odds of physical frailty and prevalent sarcopenia at baseline and follow-up and incident sarcopenia. 2782 participants with an age 66.4 ± 9.9 years and dCML intake 3.3 ± 1.3 mg/day, had data on sarcopenia at both time points. Of whom 84 had sarcopenia at baseline and 73 developed sarcopenia at follow-up. We observed an association of one SD increase in dCML intake with prevalent sarcopenia at baseline [odds ratio, OR = 1.27 (1.01–1.59)] and no association of dCML with incident sarcopenia at 5-year follow-up [OR = 1.12 (0.86–1.44)]. For frailty we analyzed 3577 participants, of whom 1972 were pre-frail and 158 were frail. We observed no association of dCML with either pre-frailty [OR = 0.99 (0.91–1.07)] or frailty [OR = 1.01 (0.83–1.22)] when non-frail subjects were used as reference. Our results show an association of dAGEs with sarcopenia cross-sectionally but not longitudinally where inconclusive findings are observed possibly due to a very low incidence of sarcopenia. There was no association with frailty cross-sectionally.
    Keywords Advanced glycation end products ; Carboxymethyllysine ; Diet ; Frailty ; Sarcopenia
    Subject code 796
    Language English
    Publishing country nl
    Document type Article ; Online
    ZDB-ID 632515-4
    ISSN 1873-2763 ; 8756-3282
    ISSN (online) 1873-2763
    ISSN 8756-3282
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top